Chinese Academy of Medical Sciences

🇨🇳China

Country: 🇨🇳China

Ownership: Private, Subsidiary

Established: 2004-07-08

Employees: -

Market Cap: -

Website: http://www.pinganzhengxing.com

Clinical Trials

Chidamide for Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Phase 2

Conditions: Experimental

Interventions: Drug: Chidamide

First Posted Date: 2018-01-25

Last Posted Date: 2018-01-25

Lead Sponsor: Chinese Academy of Medical Sciences

Target Recruit Count: 40

Registration Number: NCT03410004

Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer

Phase 2

Conditions: Anal Cancer

Interventions: Radiation: Chemo-radiotherapy with IMRT technique
Drug: Capecitabine
Drug: Mitomycin C

First Posted Date: 2017-12-22

Last Posted Date: 2018-01-30

Lead Sponsor: Chinese Academy of Medical Sciences

Target Recruit Count: 27

Registration Number: NCT03381352

Locations: 🇨🇳
Chinese academy of medical sciences, Beijing, Beijing, China

FSRT Combined With TMZ for Large BMs: a PSM Study

Completed

Conditions: Chemotherapy
Brain Metastases
Radiotherapy

Interventions: Radiation: fractionated stereotactic radiotherapy

First Posted Date: 2017-11-09

Last Posted Date: 2017-11-09

Lead Sponsor: Chinese Academy of Medical Sciences

Target Recruit Count: 72

Registration Number: NCT03338075

Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03

Phase 3

Conditions: IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer

Interventions: Radiation: SIB-IMRT
Drug: Paclitaxel
Drug: Platinum-Based Drug
Other: Involved Field Irradiation (IFI)

First Posted Date: 2017-11-01

Last Posted Date: 2019-01-02

Lead Sponsor: Chinese Academy of Medical Sciences

Target Recruit Count: 2

Registration Number: NCT03328234

Locations: 🇨🇳
Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China

Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery

Not Applicable

Completed

Conditions: Breast Cancer Female

Interventions: Radiation: Radiation therapy

First Posted Date: 2017-10-25

Last Posted Date: 2019-01-31

Lead Sponsor: Chinese Academy of Medical Sciences

Target Recruit Count: 90

Registration Number: NCT03320421

Locations: 🇨🇳
National Cancer Center/Cancer Hosptial, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China

Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02

Phase 3

Conditions: Esophageal Neoplasms

Interventions: Radiation: SIB-IMRT
Drug: Paclitaxel
Drug: Platinum-Based Drug

First Posted Date: 2017-10-12

Last Posted Date: 2019-01-02

Lead Sponsor: Chinese Academy of Medical Sciences

Target Recruit Count: 164

Registration Number: NCT03308552

Locations: 🇨🇳
Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, Beijing, China

Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01

Completed

Conditions: Esophagus Cancer
Radiotherapy Side Effect
Chemoradiation
Chemotherapy Effect

First Posted Date: 2017-10-02

Last Posted Date: 2019-01-02

Lead Sponsor: Chinese Academy of Medical Sciences

Target Recruit Count: 2762

Registration Number: NCT03298204

Locations: 🇨🇳
Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China

The Phase IVd of Inactivated Enterovirus 71 Vaccine

Phase 4

Conditions: Hand, Foot and Mouth Disease (HFMD)

Interventions: Biological: two measles attenuated live vaccine
Biological: live attenuated Japanese encephalitis vaccine
Biological: EV71 and attenuated Japanese encephalitis vaccine
Biological: EV71 and two measles attenuated live vaccine
Biological: EV71 vaccine

First Posted Date: 2017-09-28

Last Posted Date: 2017-09-28

Lead Sponsor: Chinese Academy of Medical Sciences

Target Recruit Count: 1220

Registration Number: NCT03296410

Locations: 🇨🇳
Guangdong Province Center for Diseases Control and Prevention, Guangzhou, Guangdong, China

Comparative Study of Different Neoadjuvant Therapies Before Radical Hysterectomy in Stage Ib2-IIa2 Cervical Cancer

Not Applicable

Completed

Conditions: Cervical Cancer

Interventions: Radiation: combination group
Drug: chemotherapy group

First Posted Date: 2017-08-09

Last Posted Date: 2017-08-09

Lead Sponsor: Chinese Academy of Medical Sciences

Target Recruit Count: 120

Registration Number: NCT03243825

Locations: 🇨🇳
Cancer Hospital, Chinese Acadamy of Medical Sceinces, Beijing, China

The Phase IVc of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell)

Phase 4

Conditions: Hand, Foot and Mouth Disease (HFMD)

Interventions: Biological: Inactivated EV71 vaccine (human diploid cell, KMB-17)

First Posted Date: 2017-08-07

Last Posted Date: 2017-09-06

Lead Sponsor: Chinese Academy of Medical Sciences

Target Recruit Count: 800

Registration Number: NCT03240744

Locations: 🇨🇳
Hubei Province Center for Diseases Control and Prevention, Wuhan, Hubei, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy